A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Analysis of pharmacotherapeutic approach in patients with hyperthyroidism
Analiza farmakoterapijskog pristupa kod pacijenata obolelih od hipertireoze
2022
Medicinski Podmladak
Analiza farmakoterapijskog pristupa kod pacijenata obolelih od hipertireoze
Hyperthyroidism represents a condition that occurs due to increased synthesis of thyroid hormones (T3, T4). In 90% of all cases it is caused by: Graves' disease, toxic multinodular goiter and toxic adenoma. Therapy of hyperthyroidism includes medication, radioiodine treatment and surgery. The most prescribed antithyroid drugs belong to the thioamide group (thiamazole and propylthiouracil). Aim: The aim of this study was to analyze the preoperative pharmacotherapeutic approach with the use of 3
doi:10.5937/mp73-33395
fatcat:rz5i2jedqrf6vlmqq5qb7aea5i